Cargando…
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
Cancer development and chemo-resistance are often due to impaired functioning of the p53 tumor suppressor through genetic mutation or sequestration by other proteins. In glioblastoma multiforme (GBM), p53 availability is frequently reduced because it binds to the Murine Double Minute-2 (MDM2) oncopr...
Autores principales: | Costa, Barbara, Bendinelli, Sara, Gabelloni, Pamela, Da Pozzo, Eleonora, Daniele, Simona, Scatena, Fabrizio, Vanacore, Renato, Campiglia, Pietro, Bertamino, Alessia, Gomez-Monterrey, Isabel, Sorriento, Daniela, Del Giudice, Carmine, Iaccarino, Guido, Novellino, Ettore, Martini, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747081/ https://www.ncbi.nlm.nih.gov/pubmed/23977270 http://dx.doi.org/10.1371/journal.pone.0072281 |
Ejemplares similares
-
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
por: Daniele, Simona, et al.
Publicado: (2015) -
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53
por: Sorriento, D, et al.
Publicado: (2015) -
DTNQ-Pro, a Mimetic Dipeptide, Sensitizes Human Colon Cancer Cells to 5-Fluorouracil Treatment
por: Gomez-Monterrey, Isabel, et al.
Publicado: (2013) -
Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor
por: Musella, Simona, et al.
Publicado: (2016) -
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors
por: Vernieri, Ermelinda, et al.
Publicado: (2013)